ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Rinvoq 15 mg, Retardtabletten - 28
67257001 AbbVie AG
Rinvoq 15 mg, Retardtabletten20.01.2020
  20.01.2020
(L04AF03) 
WHO-DDD 
07.15.28
07.15. 
B  
Yes 
IPCI
765.24Yes
    
10 %848.65
  
7680672570013Synthetika
7766315 
Composition
upadacitinibum 15 mg ut upadacitinibum hemihydricum, cellulosum microcristallinum, hypromellosum, mannitolum, acidum tartaricum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, E 171, E 172 (nigrum), E 172 (rubrum), pro compresso obducto.
Packungsbestandteile
Delayed release tablets 
 
Active AgentDose
Upadacitinibum15 mg
BAG: Active AgentDose
Upadacitinibum15 mg
 
Inactive agentsDoseadditional_information
(Nigrum)  
(Rubrum)  
Tartaric Acid  
Cellulosum Microcristallinum  
E 171 color.
E 172 color.
Hypromellosum  
Macrogol3350  
Magnesii Stearas  
Mannitol  
Poly(Alcohol Vinylicus) Überzug
Pro Compresso Obducto  
Silica Colloidalis Anhydrica  
Talcum  
 
Source
Data was imported : 04.07.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home